Effects of mobile intelligent cognitive training on the rehabilitation in patients with post-stroke cognitive impairment in the community
10.3969/j.issn.1001-1242.2024.11.014
- VernacularTitle:移动智能认知训练对社区卒中后认知功能障碍者康复效果的影响
- Author:
Kaiyue HAN
1
,
2
;
Jiangyi LI
;
Baodi CHEN
Author Information
1. 首都医科大学康复医学院,北京市,100068
2. 中国康复研究中心北京博爱医院
- Keywords:
stroke;
cognitive dysfunction;
mobile intelligent cognitive training;
community;
rehabilitation
- From:
Chinese Journal of Rehabilitation Medicine
2024;39(11):1651-1655,1661
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effects of mobile intelligent cognitive training(MICT)on cognitive function,ac-tivities of daily living,and quality of life of patients with mild to moderate cognitive impairment after stroke in the community. Method:Ninty-two patients with mild to moderate cognitive impairment after stroke in the community were randomly divided into experimental group(n=46)and control group(n=46).Both groups received comprehen-sive management,and the experimental group received additional MICT for 12 weeks.The Mini-Mental State Examination(MMSE),Montreal Cognitive Assessment(MoCA),Prospective and Retrospective Memory Ques-tionnaire(PRMQ),Modified Barthel Index(MBI),Functional Activities Questionnaire(FAQ),and Quality of Life Index(QLI)were assessed before,4 weeks and 8 weeks after treatment,and 1-month follow-up after the end of treatment. Result:Before treatment,there was no significant difference in all scores between the two groups(P＞0.05).After 6 weeks of treatment,the MMSE,PRMQ,MBI,FAQ,and QLI scores of the two groups were im-proved(P＜0.05),and the MoCA,MBI,and QLI scores of the experimental group were higher than those of the control group(P＜0.05);After 12 weeks of treatment and 1 month of follow-up,the scores of MMSE,MoCA,PRMQ,MBI,FAQ,and QLI were significantly improved in two groups(P＜0.05),and all scores of the experimental group were better than those of the control group(P＜0.05). Conclusion:MICT can improve cognitive function,activities of daily living,and quality of life in patients with mild to moderate cognitive impairment after stroke in the community,with efficacy lasting at least 1 month.
